Developer of virus based cancer therapies and therapeutic vaccines for viral liver diseases. The company utilizes IBDV technology for research on Viral hepatitis and Hepatocellular carcinoma. The company commercializes products for Cancer Virotherapy, Cancer Vaccines, Prophylactic and Therapeutic Vaccines.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
11. Merger/Acquisition | 23-Oct-2012 | Completed | ||||
10. Grant | 22-Jul-2009 | 00000 | Completed | |||
9. Grant | 17-Sep-2008 | 00000 | Completed | |||
8. Grant | 21-Feb-2008 | 00000 | Completed | |||
7. Grant | 01-Jan-2008 | 00000 | Completed | |||
6. Grant | 01-Jan-2007 | 00000 | Completed | |||
5. Grant | 01-Jan-2006 | 00000 | Completed | |||
4. Grant | 01-Jan-2002 | 00000 | Completed | |||
3. Grant | 01-Jan-2001 | $170K | Completed | |||
2. Grant | 01-Jan-1999 | $350K | Completed |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
David Curiel Ph.D | Chief Scientific Officer & Founder |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Greer Capital Advisors | Venture Capital | Minority | 000 0000 | 000000 0 |